Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
3 February 2012
IN THIS ISSUE
New February issue
Social media
Injectables
Nanomedicines
 
Digital pharma magazine revamp
Our new-look digital magazine tackles some of the hottest trends in the pharmaceutical industry including self-administration, nanomedicines, cloud computing and the FDA on social media. Take a look at the February issue. More...
 
FDA social media insight
Our news roundup brings you up to date on the FDA’s social media guidance, Takeda’s job cuts, a call to end animal experiments and a report on outsourcing. More...
 
Pointed debate
Our roundtable of experts discuss why pharma companies are increasingly developing injectable products that can be self-administered by patients outside of traditional healthcare settings. More...
 
Decoding the hype and fear of nanomedicines
Is nanotechnology a cure-all or a kill-all? We find out about the realistic expectations and potential of nano-enabled pharmaceutical products. More...
 
Pharma's head in the clouds
Although some pharma companies have invested in cloud computing, many opportunities are still being missed. We speak with IT firm Infosys to discover how the data storage capabilities of cloud computing can benefit pharma and what impact the technology will have in the future. More...

Key Topics:
Latest blog posts
How science and strategic collaboration led to a new, "personalized" cystic fibrosis treatment for some patients
Roche makes bid to advance position in personalised medicine
Personalising for better products
More blog posts

Latest news
Pharma targets tropical diseases
EC closes Servier investigation
FDA files consent decree against Ranbaxy
More news

Upcoming events
Informex (14–17 February | USA)
Pharmapack (15–16 February | France)
World Generic Medicines Congress Europe (28 February–1 March | UK)
More events

Products/Service Profiles
Shimadzu

Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes.
Read more

 
Jones Lang LaSalle

Specialist chemicals plant for sale in Church Village, South Wales.  Clariant Chemicals to dispose of Parabens & Polymer production facility, Jones Lang LaSalle’s Cardiff office instructed to market.
Read more

 
Survey
What is the most important change that has influenced chemical API manufacturing during the past 10 years?
Advancements in chemocatalysis (for use in asymmetric hydrogenation and other asymmetric syntheses) 13%
 
Adoption of biocatalysis in organic chemical synthesis 11%
     
Development of microreactors for continuous manufacturing 16%
     
Application of quality-by-design principles in process development and manufacturing 60%

This week we would like to know...

Which is your preferred social media tool for professional use?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail at Advanstar Communications Inc., Bridgegate Pavilion, Chester Business Park, Wrexham Road, Chester CH4 9QH.